-Search query
-Search result
Showing all 39 items for (author: fink & ea)
EMDB-27025:
CRYO-EM STRUCTURE OF HUMAN 15-PGDH IN COMPLEX WITH SMALL MOLECULE SW222746
Method: single particle / : Huang W, Taylor DJ
EMDB-29005:
human 15-PGDH with NADH bound
Method: single particle / : Huang W, Taylor D
PDB-8cwl:
Cryo-EM structure of Human 15-PGDH in complex with small molecule SW222746
Method: single particle / : Huang W, Taylor DJ
EMDB-27010:
CRYO-EM STRUCTURE OF HUMAN 15-PGDH IN COMPLEX WITH SMALL MOLECULE SW209415
Method: single particle / : Huang W, Taylor DJ
PDB-8cvn:
Cryo-EM Structure of Human 15-PGDH in Complex with Small Molecule SW209415
Method: single particle / : Huang W, Taylor DJ
EMDB-32331:
Cryo-EM structure of the alpha2A adrenergic receptor GoA signaling complex bound to a G protein biased agonist
Method: single particle / : Xu J, Fink EA, Shoichet BK, Du Y
EMDB-32342:
Cryo-EM structure of the alpha2A adrenergic receptor GoA signaling complex bound to a biased agonist
Method: single particle / : Xu J, Fink EA, Shoichet BK, Du Y
EMDB-23717:
SARS-CoV-2 S-NTD + Fab CM25
Method: single particle / : Johnson NV, Mclellan JS
PDB-7m8j:
SARS-CoV-2 S-NTD + Fab CM25
Method: single particle / : Johnson NV, Mclellan JS
EMDB-22491:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22492:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22494:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22497:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22506:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22507:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22508:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (three receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22512:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22516:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22517:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv2:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv4:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv6:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jva:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jvc:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jw0:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22659:
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22660:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22668:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
Method: single particle / : Tortorici M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k43:
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k45:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k4n:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
Method: single particle / : Tortorici M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22221:
SARS-CoV-2 HexaPro S One RBD up
Method: single particle / : Wrapp D, Hsieh CL, Goldsmith JA, McLellan JS
EMDB-22222:
SARS-CoV-2 HexaPro S Two RBD up
Method: single particle / : Wrapp D, Hsieh CL, Goldsmith JA, McLellan JS
PDB-6xkl:
SARS-CoV-2 HexaPro S One RBD up
Method: single particle / : Wrapp D, Hsieh CL, Goldsmith JA, McLellan JS
EMDB-21864:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-21865:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-6wps:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-6wpt:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)